Skip to main content
Clinical Trials/TCTR20210518001
TCTR20210518001Not yet recruitingPhase 2

Effect of oral dexamethasone for prevention of postembolization syndrome after hepatic conventional transarterial chemoembolization: A prospective randomized, double blinded, placebo controlled trial

THE GASTROENTEROLOGICAL ASSOCIATION OF THAILAND0 sites98 target enrollmentStarted: May 18, 2021Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
98

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 80 Years (—)
Sex
All

Inclusion Criteria

  • 1. Hepatocellular carcinoma
  • 2. Child-Pugh score <= 7
  • 3. Indication for treatment with TACE

Exclusion Criteria

  • 1.Main portal vein thrombosis
  • 2.SMV and IVC thrombosis
  • 3.Hepatosystemic shunt
  • 4.Tumor size > 50% of liver or > 10 cm
  • 5.Bile duct obstruction
  • 8.HR<50/min
  • 9.TB>3mg/dl
  • 10.ANC<1500
  • 11.Platelet<80,000
  • 12.INR>1.5
  • 14.Uncontrolled heart disease
  • 15.Active infection
  • 16.HIV infection
  • 17.Uncontrolled DM
  • 18.Untreated HBV infection
  • 19.Fever or nausea/vomiting
  • 20.Steroid or NSAIDs use
  • 21.Other malignancy within 3 years
  • 22.Pregnancy

Investigators

Similar Trials